1. Home
  2. KW vs BBNX Comparison

KW vs BBNX Comparison

Compare KW & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KW
  • BBNX
  • Stock Information
  • Founded
  • KW 1977
  • BBNX 2015
  • Country
  • KW United States
  • BBNX United States
  • Employees
  • KW N/A
  • BBNX N/A
  • Industry
  • KW Real Estate
  • BBNX Medical/Dental Instruments
  • Sector
  • KW Finance
  • BBNX Health Care
  • Exchange
  • KW Nasdaq
  • BBNX Nasdaq
  • Market Cap
  • KW 1.3B
  • BBNX 1.2B
  • IPO Year
  • KW 1992
  • BBNX 2025
  • Fundamental
  • Price
  • KW $9.84
  • BBNX $31.36
  • Analyst Decision
  • KW Hold
  • BBNX Strong Buy
  • Analyst Count
  • KW 1
  • BBNX 11
  • Target Price
  • KW $11.00
  • BBNX $28.09
  • AVG Volume (30 Days)
  • KW 1.5M
  • BBNX 546.0K
  • Earning Date
  • KW 11-05-2025
  • BBNX 10-28-2025
  • Dividend Yield
  • KW 4.93%
  • BBNX N/A
  • EPS Growth
  • KW N/A
  • BBNX N/A
  • EPS
  • KW N/A
  • BBNX N/A
  • Revenue
  • KW $550,500,000.00
  • BBNX $88,570,000.00
  • Revenue This Year
  • KW N/A
  • BBNX $52.13
  • Revenue Next Year
  • KW $2.36
  • BBNX $36.07
  • P/E Ratio
  • KW N/A
  • BBNX N/A
  • Revenue Growth
  • KW 13.93
  • BBNX 67.01
  • 52 Week Low
  • KW $5.98
  • BBNX $8.89
  • 52 Week High
  • KW $11.78
  • BBNX $32.71
  • Technical
  • Relative Strength Index (RSI)
  • KW 66.76
  • BBNX 69.57
  • Support Level
  • KW $9.45
  • BBNX $26.13
  • Resistance Level
  • KW $9.94
  • BBNX $32.41
  • Average True Range (ATR)
  • KW 0.18
  • BBNX 1.97
  • MACD
  • KW 0.02
  • BBNX 0.30
  • Stochastic Oscillator
  • KW 80.56
  • BBNX 81.94

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: